Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

List of Diagnostics Stocks 

Here are the latest stock price details of India's top Diagnostics stocks. For more detailed updates, check the latest Diagnostics sector results.

Revealing Soon: A Potential Huge Investing Opportunity for Investors

SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
DR. LAL PATHLABS 2,577.75 -0.32% 2,581.20 -0.19%
 More Info 
GLOBAL HEALTH 1,202.50 -3.10% 1,201.80 -3.10%
 More Info 
KRSNAA DIAGNOSTICS 593.55 0.24% 593.35 0.46%
 More Info 
METROPOLIS HEALTHCARE 1,945.90 -0.56% 1,946.85 -0.47%
 More Info 
NIFTY 50 Not Listed 22,967.65 1.64%
 More Info 
RAINBOW CHILDRENS MEDICARE 1,248.60 -0.89% 1,249.50 -0.77%
 More Info 
S&P BSE SENSEX 75,418.04 1.61% Not Listed
 More Info 
THYROCARE TECHNOLOGIES 628.95 0.03% 629.25 0.39%
 More Info 
VIJAYA DIAGNOSTIC 777.15 -0.46% 776.50 -0.57%
 More Info 

BSE prices: May 23, 2024  (Close)    NSE prices: May 23, 2024  (Close)

Diagnostics Stocks Update

Within the Diagnostics sector, the top gainers were KRSNAA DIAGNOSTICS (up 0.2%) and THYROCARE TECHNOLOGIES (up 0.0%). On the other hand, GLOBAL HEALTH (down 3.1%) and BANDARAM PHARMA PACKTECH (down 1.9%) were among the top losers.

Meanwhile, the benchmark S&P BSE SENSEX was at 75,418.0 (up 1.6%).

Before you go, here are the upcoming corporate actions for Diagnostics stocks.

Upcoming Dividends

COMPANY PRICE (Rs) CHANGE (%) DIVIDEND (%) RECORD DATE EX-DIVIDEND DATE
DR. LAL PATHLABS 2,577.75 -0.32 60.0 10-Jun-24 10-Jun-24

List of All Upcoming Dividends



FAQs

Which are the top diagnostics companies in India?

Based on marketcap, these are the top diagnostics companies in India:

You can see the full list of diagnostics stocks here.

And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for best diagnostics companies in India.

Which are the top gainers and top losers within the diagnostics sector today?

Within the Diagnostics sector, the top gainers were KRSNAA DIAGNOSTICS (up 0.2%) and THYROCARE TECHNOLOGIES (up 0.0%). On the other hand, GLOBAL HEALTH (down 3.1%) and BANDARAM PHARMA PACKTECH (down 1.9%) were among the top losers.

For more, please visit the BSE healthcare index live chart and also check out our pharma sector report.

How should you value diagnostics companies?

Investing in stocks requires careful analysis of financial data to find out a company's true worth. However, an easier way to find out about a company's performance is to look at its financial ratios.

Two commonly used financial ratios used in the valuation of stocks are -

Price to Earnings Ratio (P/E) - It compares the company's stock price with its earnings per share. The higher the P/E ratio, the more expensive the stock.

Price to Book Value Ratio (P/BV) - It compares a firm's market capitalization to its book value. A high P/BV indicates markets believe the company's assets to be undervalued and vice versa.

To know more about the healthcare sector's past and ongoing performance, have a look at the performance of the NIFTY healthcare index and BSE healthcare index.

Which are some important indices one should track?

Well, it depends on what your goals are.

Having said that, the two key indices to track are the BSE Sensex which contains the list of BSE 30 stocks and the NSE Nifty which contains the list of NSE 50 stocks.

However, these two indices are considered to be too narrow by some, since they only track 30 and 50 stocks, respectively.

For broader tracking, you could use the BSE 200, BSE 500 or even the NSE 500 index.

Some popular market cap based indices include BSE Smallcap index and BSE Midcap index, among others.


Today's Market

Sensex Today Ends at Record Highs, Rallies 1,197 Points | Nifty Nears 23,000 Mark | 3 Reasons Why Indian Share Market is Rising Sensex Today Ends at Record Highs, Rallies 1,197 Points | Nifty Nears 23,000 Mark | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.